Synonyms: compound A [PMID: 26582730] | compound C [PMID: 29025977] [3] | T662
Compound class:
Synthetic organic
Comment: This compound is a selective M1 muscarinic acetylcholine receptor positive allosteric modulator [3]. In vivo it induces cholinergic side effects such as salivation, diarrhea, and emesis [2].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Abdul-Ridha A, Lane JR, Mistry SN, López L, Sexton PM, Scammells PJ, Christopoulos A, Canals M. (2014)
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. J Biol Chem, 289 (48): 33701-11. [PMID:25326383] |
2. Alt A, Pendri A, Bertekap Jr RL, Li G, Benitex Y, Nophsker M, Rockwell KL, Burford NT, Sum CS, Chen J et al.. (2016)
Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors. J Pharmacol Exp Ther, 356 (2): 293-304. [PMID:26582730] |
3. Kurimoto E, Matsuda S, Shimizu Y, Sako Y, Mandai T, Sugimoto T, Sakamoto H, Kimura H. (2018)
An Approach to Discovering Novel Muscarinic M1 Receptor Positive Allosteric Modulators with Potent Cognitive Improvement and Minimized Gastrointestinal Dysfunction. J Pharmacol Exp Ther, 364 (1): 28-37. [PMID:29025977] |